GlassScriptPhysician profile
Kaylee N Lee
NPI 1215590138
$6,606.11
in general payments reported to CMS, 2019-2025
25 companies · $2,753 in 2025
The $2,753 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $788 · 2024: $3,066 · 2025: $2,753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,321 · Education: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,320.66 |
| Education | $285.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,365.85 | 2023-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $1,141.59 | 2023-2025 | Dupixent, Libtayo |
| Abbvie INC. | $1,011.83 | 2023-2025 | |
| Galderma Laboratories, L.P. | $477.10 | 2025 | Nemluvio |
| Ucb, INC. | $376.34 | 2024-2025 | Bimzelx |
| Incyte Corporation | $370.41 | 2023-2025 | Opzelura, Opzelura |
| Sun Pharmaceutical Industries INC. | $366.18 | 2023-2025 | Odomzo, Blu-U, Ilumya |
| Novartis Pharmaceuticals Corporation | $300.06 | 2023-2025 | |
| Pfizer INC. | $253.62 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $139.42 | 2024-2025 | Zoryve |
| Lilly USA, LLC | $119.10 | 2023-2024 | Olumiant |
| Verrica Pharmaceuticals INC. | $116.74 | 2024-2025 | Ycanth |
| Genzyme Corporation | $111.95 | 2024-2025 | |
| Organon LLC | $92.43 | 2025 | Vtama, Nexplanon |
| Leo Pharma INC. | $87.56 | 2023-2025 | Adbry |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $54.83 | 2024-2025 | Poteligeo |
| E.R. Squibb & Sons, L.L.C. | $44.00 | 2024 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $38.27 | 2024 | Jublia |
| Organogenesis INC. | $23.11 | 2025 | Simplimax |
| Fidia Pharma USA INC. | $23.11 | 2025 | |
| Lnhc, INC | $21.86 | 2025 | Zelsuvmi |
| Dermavant Sciences, INC. | $20.59 | 2024 | Vtama |
| Mimedx Group, INC. | $18.85 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.36 | 2025 | Spevigo |
| Biowound Solutions, INC. | $12.95 | 2025 | Bio-Connekt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaylee Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.